Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended June 2024 as against Rs 3.36 crore during the previous quarter ended June 2023. Sales declined 8.51% to Rs 33.45 crore in the quarter ended June 2024 as against Rs 36.56 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 33.45 | 36.56 | -9 |
| OPM % | 4.96 | 16.90 | - |
| PBDT | 2.50 | 5.24 | -52 |
| PBT | 1.65 | 4.53 | -64 |
| NP | 1.34 | 3.36 | -60 |